- Home
- KEP vs PODD Comparison
KEP vs PODD Comparison
Compare KEP & PODD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KEP | PODD |
|---|---|---|
| Founded | 1961 | 2000 |
| Country | South Korea | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 21.5B | 21.0B |
| IPO Year | N/A | 2007 |
Fundamental Metrics
Financial Performance| Metric | KEP | PODD |
|---|---|---|
| Price | $21.56 | $271.78 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 19 |
| Target Price | N/A | ★ $367.32 |
| AVG Volume (30 Days) | 598.9K | ★ 641.0K |
| Earning Date | 03-10-2026 | 02-18-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 122.08 | N/A |
| EPS | ★ 9.13 | 3.45 |
| Revenue | ★ $69,245,145,923.00 | $2,521,800,000.00 |
| Revenue This Year | $5.36 | $32.55 |
| Revenue Next Year | $2.32 | $20.47 |
| P/E Ratio | ★ $4.58 | $81.14 |
| Revenue Growth | 5.27 | ★ 27.11 |
| 52 Week Low | $7.03 | $230.05 |
| 52 Week High | $23.41 | $354.88 |
Technical Indicators
Market Signals| Indicator | KEP | PODD |
|---|---|---|
| Relative Strength Index (RSI) | 67.05 | 33.24 |
| Support Level | $18.35 | $275.10 |
| Resistance Level | $23.41 | $288.98 |
| Average True Range (ATR) | 0.46 | 9.17 |
| MACD | 0.49 | -0.20 |
| Stochastic Oscillator | 71.22 | 15.58 |
Price Performance
Historical ComparisonAbout KEP Korea Electric Power Corporation
Korea Electric Power Corp is an electric utility company in which the government of South Korea holds a controlling stake. The firm operates in the following segments: Transmission and distribution, Electric power generation (Nuclear), Electric power generation (Non-Nuclear), Plant maintenance & engineering service, and Others. The majority of the energy produced by the company comes from its nuclear and coal-fired assets. Korea Electric Power generates revenue through the Transmission and distribution segment. Geographically, it derives maximum revenue from Domestic operations.
About PODD Insulet Corporation
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the US Food and Drug Administration in 2005, approximately 500,000 insulin-dependent diabetic patients are using it worldwide.